Abstract
Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: The Orcharrd Study (OMB110928)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have